Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRFS | RVMD | ALPN | ||
| Company | Grifols S.A. ADR | Revolution Medicines Inc | Alpine Immune Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.33 | 34.94 | 64.57 | ||
| High | 6.37 | 35.83 | 64.65 | ||
| Low | 6.12 | 34.68 | 64.54 | ||
| Last | 6.27 | 35.33 | 64.62 | ||
| Change | -0.12 | -0.26 | +0.05 | ||
| % Change | -1.88% | -0.73% | +0.08% | ||
| Volume | 1,012,213 | 1,192,512 | 1,768,714 | ||
| 20-Day Average Volume | 1,361,056 | 1,385,196 | 4,314,965 | ||
| Previous Close | 6.39 | 35.59 | 64.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.69 | 34.27 | 53.07 | ||
| 20-Day Raw Stochastic | 12.20% | 62.96% | 99.74% | ||
| 20-Day Relative Strength | 42.51% | 57.00% | 80.80% | ||
| Weighted Alpha | -4.85 | +84.80 | +308.10 | ||
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.13% since 04/18/24 | -1.40% since 04/18/24 | +0.29% since 04/18/24 | ||
| Low | 6.12 on 04/25/24 | 34.23 on 04/19/24 | 64.40 on 04/19/24 | ||
| High | 6.66 on 04/23/24 | 37.87 on 04/23/24 | 64.70 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -1.42% since 03/25/24 | +16.37% since 03/25/24 | +72.09% since 03/25/24 | ||
| Low | 6.12 on 04/25/24 | 29.55 on 04/05/24 | 34.25 on 04/08/24 | ||
| High | 7.35 on 04/09/24 | 38.73 on 04/11/24 | 64.70 on 04/23/24 | ||
| 3-Month | |||||
| %Chg | -17.82% since 01/25/24 | +26.31% since 01/25/24 | +197.24% since 01/25/24 | ||
| Low | 5.30 on 03/06/24 | 26.95 on 01/29/24 | 21.92 on 01/26/24 | ||
| High | 9.37 on 02/28/24 | 38.73 on 04/11/24 | 64.70 on 04/23/24 | ||
| 6-Month | |||||
| %Chg | -19.20% since 10/25/23 | +76.56% since 10/25/23 | +636.83% since 10/25/23 | ||
| Low | 5.30 on 03/06/24 | 18.00 on 10/31/23 | 8.33 on 10/26/23 | ||
| High | 12.15 on 12/29/23 | 38.73 on 04/11/24 | 64.70 on 04/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,393,509 | 5,861,318 | 4,232,305 | ||
| Shares Outstanding, K | 687,560 | 164,690 | 65,546 | ||
| Annual Sales | 7,134,500,000 | 11,580,000 | 58,880,000 | ||
| Annual Net Income | 131,340,000 | -436,370,000 | -32,180,000 | ||
| Last Quarter Sales | 2,025,030,000 | 740,000 | 30,850,000 | ||
| Last Quarter Net Income | 125,920,000 | -161,540,000 | 5,960,000 | ||
| 60-Month Beta | 0.56 | 1.54 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 07/27/23 | -1.14 on 02/26/24 | 0.15 on 03/18/24 | ||
| Latest Earnings Date | 03/05/24 | 05/13/24 | 05/09/24 | ||
| Most Recent Dividend | 0.370 on 06/03/21 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/03/21 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||